These findings suggest that CEA expression may play a role in the development of cisplatin resistance, underscoring the potential involvement of CEA in NSCLC proliferation, migration, invasion, and drug resistance. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.